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ABSTRACT 
Introduction The prevalence of obesity is increasing in all segments of the population. 
While excess body mass is associated with increased disease risks, the magnitude of the 
risks are unclear from existing studies. In this dissertation we examine the association 
between BMI and cardiovascular outcomes, CHD, stroke and CVD mortality and blood 
pressure in four gender-race subgroups. 
Methods This study uses Black Pooling Project data which includes subject level data 
on 27,691 men and women and 450,962 person-years of follow-up. Analysis includes 
linear regression and Cox Proportional Hazard models and is gender-race specific. 
Subject-level meta-analysis is used to obtain overall estimates of effect. 
Results: As a group, blacks have a higher adjusted mean systolic blood pressure than 
whites and are classified as hypertensive at all BMI categories whereas in whites blood 
pressure did not reach the hypertensive range until a BMI of at least 31 kg/m2 . The age-
adjusted rise in blood pressure for a BMI increase of25-30 kg/m2, is greater for white 
than black women (5.9±0.2 vs. 4.4±0.5 p=0.005) and for white than black men (6.0±0.3 
vs. 4.3±0.7 p=0.03). The adjusted relative risks for CHD, stroke and CVD mortality is 
significant for obesity in whites but not in blacks. In obese whites, the relative risk for 
C\lD mortality is (1.59[l.20-2.09]) in women <60 years and (1.21 [1.04-1.41]) in women 
>60 years. There are no such significant associations for black women. 
Conclusions Obesity has a greater impact on blood pressure and CHD, stroke and CVD 
mortality in whites than blacks. While obesity prevention and treatment are 
recommended for all, these findings suggest that these efforts will have a greater impact 




The prevalence of overweight and obesity is increasing in men and women of all 
races/ethnicities1;2. However, compared to whites, blacks have a higher prevalence of 
cardiovascular risk factors including obesity and hypertension.3 ;4 While obesity-related 
health risks are similar in all populations the risk associated with a given amount of 
excess weight may vary with race, gender and age. 5 
The purpose of this dissertation is to examine the racial disparities in the 
association between body mass index (BMI) and blood pressure and between BMI and 
stroke, coronary heart disease (CHD), and cardiovascular disease (CVD) mortality 
separately in men and women. 
Chapter 1 is comprised of a brief introduction to the dissertation, specific aims 
and an expanded review of the literature to provide additional background information. 
In Chapter 2, we examine the association between BMI and blood pressure in black and 
white men and women. In Chapter 3, we look at the association between BMI and 
coronary heart disease (CHD), stroke and total cardiovascular disease (CVD) mortality in 
black and white men and women. In Chapter 4, we consider the effect of age on the 
association between BMI and CVD mortality in black and white women. Chapter 5 
provides an overall summary of the findings in this dissertation. 
1 
Specific Aims 
1. To assess the racial differences in the association between body mass index 
and blood pressure in men and women. 
2. To assess the racial differences of stroke, CHD and CVD mortality risks 
associated with body mass index in men and women. 
3. To calculate the age-specific stroke, CHD and CVD mortality risk associated 
with body mass index in younger and older black and white women. ' 
2 
Review of the Literature 
Cardiovascular Disease 
Cardiovascular disease (CVD), principally coronary heart disease (CHD) and 
stroke, accounted for 38.5% of all deaths in the United States in 2001 and has been the 
number one killer in the United States for every year except 1918 since 19006. In 2001, 
the overall age-adjusted death rate from CVD was 329.6/100,000. For the four gender-
racial groups the CVD death rates were: 384.3 white men, 273.6 white women, 510.5 
black men and 376.6 black women. Despite declines in death rates from CVD, the actual 
number of deaths is increasing and the disparity between the four gender-racial groups is 
changing. 
Historically, CI-ID mortality rates were greater in whites than blacks but since 
1980 the rates of CI-ID have been declining faster in whites. In 1989, the age-adjusted 
CI-ID mortality rates "crossed over" and the rates for black men began to exceed the rates 
for white lIlen7• Concurrently, the CHD mortality rates were 30% greater in black 
women than white women. CHD mortality also occurs earlier in life for blacks than 
whites. Before age 50, black men and women have a 50% and 100% higher death rate 
than whites, respectively. After the age of 60 another crossover occurs and mortality 
rates in blacks fall below that of whites. In 1995, the heart disease death rate was 29% 
higher tor black than white men8 and 40~/o higher in black than white women9 . 
Similar patterns are evident in stroke mortality. Stroke death rates declined 
substantially in the 1970s and 80s but little in the 1990s for all gender-racial groups 10. In 
1998, stroke death rates were 1.4 times higher in black men and \vomen than in 
3 
respective white gender groups and among blacks 490/0 of strokes occurred before age 75 
compared to only 25% in whites. 
The epidemic of heart disease and stroke can be expected to continue, with 
widening disparities and an increasing burden, primarily from the aging population 11. In 
1994, the working group on research in Coronary Heart Disease in blacks noted, "On one 
hand, investigators have acquired a rich and detailed understanding of the general 
relationships linking risk factors to CHD, and these relationships appear to be universally 
applicable. On the other hand, data from specific ethnic subpopulations are inconsistent 
in important aspects with certain findings in white men,,7. The limited availability of data 
for the black population makes it difficult to determine whether these inconsistencies are 
due to chance, reporting artifacts, or biological facts. 
Body Mass Index (BMI) and Obesity 
Body Mass Index (BMI), which represents the ratio of body weight divided by 
height squared (kg/m2), provides an overall measure of adiposity. The CDC states that 
"calculating BMI is one of the best methods for population assessment of overweight and 
obesity. It is low-cost and easy to use for clinicians and the general public". While other 
rneasures looking at body-fat distribution, such as waist circumference 12;13 may provide a 
more thorough picture of obesity, BMI is easily and regularly obtained in clinical practice 






< 18.5 kg/m2 
18.5-24.9 kg/m2 
25.0-29.9 kg/m2 
> 30 kg/m2 
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The prevalence of overweight and obese is increasing in all segments of the 
population. Over a 1 O-year period, 1991-2001, the percent of obese (BMI >= 30) persons 
increased dramatically. In the overall population, obesity increased from 120/0 in 1991 to 
20.9% in 2001, which reflects an increase of61 percent. In men and women, these 
percentages were 11.70/0 and 12.20/0 in 1991 and 210/0 and 20.8% in 2001, respectively. 
Among whites and blacks, the differences in the prevalence are much more pronounced 
with 11.3% and 19.3% in 1991 and 19.60/0 and 31.1 % in 2001 2, Similar evidence of the 
obesity epidemic was found using NHANES data which uses measured data rather than 
self-report l , In NHANES III, the age-adjusted prevalence of overweight and obesity 
were 55.9% and 22.90/0, In 1999-2000 the age-adjusted prevalence increased to 64.5% 
overweight and 30.5% obese. There was also a significant increase in extreme obesity 
(BMI>40kg/m2) from 2.9% to 4.7%. In men there was little racial difference in the 
prevalence of overweight and obesity, however in women overweight and obesity was 
highest in black women. 
In most recent estimates using NHANES data from 2003-2004, 66% of US adults 
were overweight or obese (Brvl1 >25 kg/m2), 32% were obese (BMI >30 kg/m2) and 5% 
were morbidly obese (BMI >40 kg/m2)14, The prevalence of overweight and obesity 
varied with age, and race. Overweight and obesity was greater in middle-age (40-59 
years) men and women than in younger (20-40 years) and older (>60 years) men and 
women. The prevalence of overweight and obesity was also greater in black than white 
women in all age groups. Among men, the prevalence of overweight and obesity was 
similar for blacks and whites vvith white men having a greater prevalence of overweight 
or obesity and black men having a greater prevalence of obesity and morbid obesity, 
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Race, Body Mass and Mortality 
Data from a large subject-level meta-analysis suggests that obesity is associated 
with excess mortality whereas among overweight persons there was little evidence of 
increased risk 15 • However, this relationship between body mass and mortality differs 
among races. The body mass-related increase in risk begins at a 1 to 3 kg/m2 higher BMI 
for blacks than whites5 . In NHANESINHIS, the lowest mortality was associated with a 
BMI of 27.1/30.2 kg/m2 for black men, 26.8/26.4 kg/m2 for black women, compared with 
24.8/27.1 kg/m2 and 24.3/25.6 kg/m2 for white men and women16. Obesity is also 
believed to have a profound effect on life span especially in younger adults 17. In a study 
that calculated years of life lost (YLL)~ the BMI associated with the least YLL or greatest 
longevity was approximately 23-25 kg/m2 in whites and 23-30 kg/m2 in blacks 17 .< 
A significant interaction was found to exist between ethnicity and BMI for all-
cause and CVD mortality 18. The increased risk of death associated with a high BMI has 
consistently been shown to be stronger in whites than blacksI8~19. Among persons who 
had never smoked and had no history of disease in the Cancer Prevention Study II, the 
relative risk of death from all causes for those at the highest BMI level was 2.58 in white 
men and 2.00 in white women. In black men~ the relative risk was 1.35 and not 
statistically significant and in black women there was only small (20 to 30% ) non-
significant increase in risk which was only found at the highest levels of BMI(> 35) 19. In 
the Cancer Prevention Study I, the impact of BMI on mortality was modified by 
educational status in black women. However, among women of the same education level 
BMI had a greater effect on mortality in whites than blacks. 
6 
Yet, other studies conclude that the BMI -all cause mortality association is similar 
in blacks and whites20 and others have found no association at a1l21 . 
Blood Pressure and Hypertension 
Blood pressure classification, management and therapy guidelines are provided in 
the following table from the seventh edition of the Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure(JNC7)22. 
TabJe 1. Cld,>sillC:auon and Man.lgement of Blood Pressure for Adults. Aged 18 Years or Older 
Managemvnt' r------.--- ---
Initial Drug Thetapy 
BP SystoliC Diastolic Lifeltty1e r----------·----~-------~, 
,_. Classification __ . BP, mm Hg+ _~. mm "!Y~ ModifICation Wrthout COf!Ipelling Indication With Compelling Indicationst 
_~~rmdl ____ ~ _______ ~~~2 20 __ .~r~ __ ......::~ __ 5!~?~~g€ __ ,_. ____________ , .. _~ __ _ 
?!€hypel1&ns.on ~ 2(11,19 0' 8C B9 Yes No ar.tihyp;rten:c.fYe drll] Orug~sl for the compelling 
Indlcateo !ndK:ationsl 
..... _--"-,,--,_ .. , ... _.,,"-" 
Slage 1 Ilypertens.cfl 140·159 
01 >10::' 
ThiaziOe,typ€ ddJret/Cb for most: 
(r)a~< ccnsiCtlt /I,CE inhibitor 
AHB. 11 blocker. eGA or 
comoination 
OrugiS} tor ths compeHing 
u1dlCaton:: 
Othe~ antihypertensive an.>;). 
{d,uretK"S, ACE IrV),bitof. ARB. 
,.,w,,,_~, , •• "' •••. ~ ••. " __ •.•. _._~. __ .~"'.... ..... .. ,~triOCker" .9~!.~L~~, __ 
2· Dr,...:;; combinatoi, most Dn;g(s} lor the compalli~ 
IL'suBify thlaztde·type dIuretic indica!ons 
am ACE mhibltor or Aqe or Otnar antihypArtenSIv£< dr-\~$ 
i5-bkx:k61 or CGB)§ Idiu:ebcs. ACE iMibitOf. ARB, 
'''~~_"''''_''~._'_~_. __ ." __ <"'_'''''_'"'"''_"' _____ '''_" ____ ,,,,," __ ~,,_," ___ " •• _." •• _" __ ~biOC~~:.CCB}a~needed 
At ~ 1t~;\'~3:n(lt r-~' f"\C~ i1n:;ptaH~~n Cdt i~w11tG 'K' "1' v'tt I <'J" /\HH, /tllfP1 ,li,~Ntl !"~C/l·.lfnf t:j(":;4-'~f.lf· 1H > tk~r.'d ~ )ff'SSHH~- ,.~ . f:t ~ U1:l--f',UP, ut~;.nnt'-i t:-'H:i(,k:~f 
'1'(MI"~'flt <Jet'Arlm.".! Ii, l\iqhc~'lIJI'.:fill.xj<lt\". 
ral:~(' i 
pi-.l.h<:"!rHS Wltr~ {'hr{''#~1 ~ Kylt 1\::"1 di';'i'''~(J:!-W .):f ~fh1.t"~~l~~,>{ J,r:) HP ';, ~ ~'Jt WSS thi10l 1 30t&-! ff f r:. ! ~q_ 
. (~rttitliF"' :h~~p_rt'~· ~fH.)l,.";O t~ .. 'j~;".·.!d ,-,aUi~.)HS:~i V'! ih'o:o~~ ;.,t t;S¥. vlr;!'tit Ky·;tanc ~~lX)h::ll~~<).n_ 
Hypertension affects approximately 50 million individuals in the United States with the 
prevalence expected to continue to increase as the population ages. Hypertension is 
associated with atheroschlerosis, peripheral arterial disease, cerebrovascular accidents, 
CHD, congestive heart failure, chronic renal insufficiency and failure, dementia and 
death23 . It is estimated that cardiovascular risk increases proportionally to blood pressure 
increases above 115/85 mmHg24 emphasizing the importance of adequate blood pressure 
managenlent. 
flypertension and Body Mass 
Body mass has long been recognized as a major predictor of blood pressure5~22;25-
31 but the exact nature of this relationship is unclear27 . INTERSAL T found that on 
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average a 10 kg (22Ib) difference in body weight was associated a 3.0 mmHg difference 
in systolic blood pressure and a 2.2 mmHg difference in diastolic blood pressure32. In the 
Framingham Heart Study, the relative risk of hypertension in men and women was 1.5 to 
1.7 in overweight and 2.2 to 2.6 in obese3]. A large scale study of young adults found 
blood pressure to be highly correlated with BMI in both genders33. They also found that 
while blood pressure was higher in men, as BMI increased the differences in blood 
pressure between men and women diminished suggesting that the impact of obesity on 
hypertension is more prominent in women. In ARIC, despite the increase in hypertension 
associated with increases in BMI in both genders and races, the interaction between race 
and BMI was only significant among women and among these women the odds of 
hypertension were greater for white women34 . In the elderly, BMI was significantly 
associated with hypertension in all gender-racial groups except black women35. 
The relationship between hypertension and body size was also examined In the 
South Carolina Cardiovascular Disease Prevention Project to address the question "Are 
the black-white differences in the prevalence of hypertension due to the differences in 
associated body size?" In this study the investigators concluded that just some of the race 
differences in hypertension prevalence are due to the effects of BMI and waist-to-hip 
ratio (WHR). And that ~'the racial discrepancies in BMI and WHR associations with 
blood pressure suggest a different mechanism of hypertension for black and whites as 
well as men and women".25 
Despite similar obesity-related health risks in all populations, the specific level of 
risk associated with a given level of excess weight may vary with race/ethnicity, age and 
gender. For instance, the prevalence of hypertension in obese versus non-obese 
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populations varies between races/ethnicities5. Data from ARIC showed that obesity was 
associated with increased odds of hypertension in both blacks and whites but that the 
odds ratios were much smaller in black women than white women34. 
Weight loss and management appears to be an effective method for primary 
hypertension prevention and blood pressure lowering and is included as a strategy for 
blood pressure control in the seventh edition of the Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure(JNC7)22. In 
obese hypertensives weight loss, even modest weight loss, has been shown to be the most 
effective non-pharmacological treatment approach36. A meta-analysis of twenty-five 
randomized controlled trials found that a weight loss of 1 kg ( 2.2 lbs) reduced systolic 
and diastolic blood pressure by 1.5 and 0.92mmlHg26. In the Trials of Hypertension 
Prevention II, overweight men and women without hypertension who lost 4.5 kg after 6 
months of treatment and maintained their weight loss for 30 months had a relative risk of 
hypertension of 0.3537 , Life expectancy based on a Markov model of cardiovascular 
events found that initial blood pressure did not affect the magnitude of life expectancy for 
equivalent blood pressure reductions38 , 
Obesity as a Predictive Risk Factor 
Obesity-related health risks are similar in all populations but the exact level of 
risk associated with a given amount of excess weight may vary with race, ethnicity, 
gender, age and societal conditions5. The major independent risk factors, as typically 
used by Framingham, for CI-ID prediction include: blood pressure, total cholesterol, HDL 
cholesterol, current smoking, diabetes and age39. Obesity had been considered a 
predisposing risk factor, or a factor that worsens the major independent risk factors40 , 
9 
However, a growing body of literature suggests that obesity is not only related to but 
independently predicts CVD 19;4 1;42 and coronary atheroschlerosis for both men and 
women with minimal increases in BMI43-4s . However, results in literature remain 
inconsistent. Some studies have found an association between BMI and CHD mortality 
in white men and women31 ;46;47, in white, but not black women48, and in only white 
women of lower socio-economic status49. In the combined Charleston Heart Study and 
Evans County Heart Study dataset, a higher BMI was found to have little effect (RR= 
0.97 (0.94-0.99)) on white men and weakly (RR = 1.05 (1.01-1.10)) but significantly 
associated with CHD mortality in black menso. 
Obesity is listed as a potentially modifiable risk for stroke in the American Heart 
Association guidelines51 . Some studies have found weight to be independently associated 
with stroke41 , others describe the relationship between stroke and BMI to be~ although 
lower in absolute terms. similar to that ofCHD for men but less pronounced in women46 
and others suggest that risk decreases with ageS2 . In the Physicians' Health Study the risk 
of stroke was found to be associated with increased BMI and the risk remained after 
adjusting for potential biological mediators, such as hypertension and diabetess3 . The 
authors note that hypertension and diabetes accounted for much, but not all, of the 
increased risk. In the Nurses' Health Study, obesity was found to be an important risk 
factor for ischemic and total stroke but not hemorrhagic stroke54. Others concluded no 
association between weight and stroke5S -S8 or that in the presence of other cardiovascular 
risk factors adiposity was not independently associated with stroke59 . 
Total CVD mortality has also been associated with weight41 . Some studies have 
found that the risk of CVD death is associated with a high BMI and that the risk is greater 
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for whites than blacks 19• The Chicago Heart Association Detection Project in Industry 
Study examined the long-term consequences of obesity and found an independent, direct 
positive association with CVD mortality even after controlling for variables in the causal 
pathway6o. The Framingham Heart Study found that after 26 years of follow-up each 
standard deviation increase in relative weight was associated with an increase in 
cardiovascular events of 15% in men and 22% in women61 . 
Various literature has also found that risk factors tend to cluster and that the 
clustering worsens with weight gain62 ;63. There appears to be a biologically plausible 
metabolic basis for risk factors to be affected by weight and weight gain. All elements of 
the cardiovascular risk profile are worsened by involuntary weight gain, including 
dyslipidemia, hypertension, insulin-resistant glucose intolerance, left-ventricular, 
hypertrophy, hyperuricemia and elevated fibrinogen61 • The following schematic displays 
h h . h' f b . 61 '64 teat erogenIC mee anisms 0 0 eSJty " . 
Abdor'1°beslty r Insulin iOflls1ailce l 
Glucose Intolerance Upoprotein lipase Increased $Odium 
1 daf1~8ncy reabsorption , IncreasedtlQlycerldes' t 
DI9
L
betes Decreased 101. cholesterol Hl'PjSion 
Accelerated atherqgenesls ~ , 
Age, Body Mass and Mortality 
Age is another factor that has an effect on the association between body mass and 
stroke/CHD/CvTD mortality. i\ recent article that attempted to quantify the effect of 
obesity by calculating years of life lost stated that obesity has a profound effect on 
1 1 
lifespan 17 , The usual J- or U-shaped curve was observed between BMI and years of life 
lost, with the leanest and heaviest at greatest risk. However in blacks, decreases in life 
expectancy were not observed until a BMI of 37 or 38kg/m2 in women and 32 to 33 
kg/m2 in men suggesting that body mass is not as detrimental in the black population. The 
Framingham Offspring study confirms that BMI is strongly related to age. Men reached 
a BMI plateau around age 50 whereas women experienced a constant increase in BMI 
with age until age 7065 . The age at which BMI peaks and weight loss begins varies with 
race and gender66. 
Analysis of the American Cancer Society's Cancer Prevention Study data 
including 62,116 men and 262,019 women suggests that among men and women aged 
30-74 years an increased mortality risk from CVD and all causes is associated with a 
greater body weight, however the relative risk associated with excess weight is greater in 
younger persons67 . In a historical cohort of men with a mean follow-up of 35 years, a 
strong significant association was found between BMI in young adulthood and CVD 
mortality (HR 2.41) and a weaker, non-significant association in mid-adulthood (HR 
1.33)68. i\.nd in a prospective cohort study of obese persons referred to an obesity clinic 
the risk of death increased with body weight but obesity-related excess mortality declined 
with age at all levels of 0 besity69. On the contrary, in older Finnish women, mortality 
varied little with BMI70 and in men the risks were similar for the heaviest and leanest 
Inen and greatest for those under age 7571 . In the combined ARIC and CHS dataset, there 
was little evidence in IMT difference, a measure of atherosclerosis, for BMI and 
hypertension in whites and blacks across age strata72 . 
12 
The suggestion that body mass affects people differently is not a novel idea. 
There has long been discussion that the ideal weight for elderly persons should be greater 
than younger persons 73. In an older cohort (average age 79) being heavier than 
recommended was associated with lower short-term mortality, whereas being overweight 
at younger ages was associated with increased mortality74. In the Longitudinal Study of 
Aging, obesity in older participants was associated with reduced mortality compared to 
those who were normal weight75 , and in a cohort of 70 year olds, the lowest risk for 15-
year mortality was found in those with higher BMI76. 
Other research has shown that after age 60 the prevalence of obesity decreases 77. 
The authors suggest a few explanations for this phenomenon including selective survival, 
where obese young and middle-aged persons die prematurely; cohort effect, where older 
persons come from cohorts that typically were not obese or that body fat is redistributed 
with increasing age hence BMI is not an optimal measure of body composition. However 
it is also noted that while obesity declines, fat storage is still common in the elderly, 
progressively more fat is stored in the abdominal cavity and that the weight loss 
commonly seen in the elderly is related to a loss of lean body mass. 
]3 
Black Pooling Project 
The Black Pooling Project consists of four studies (Charleston Heart Study, Evans 
County Heart Study, N;HANES I and NHANES II) and includes subject-level data on 
2,843 black women, 2,010 black men, 12,739 white women and 10,089 white men. 
Characteristics of each study in the Black Pooling Project are noted for each gender-race 
group below: 
BLACK FEMALES 
% % % tL 
mean mean !'!l!!!l !!l.!!!1 Normal Over ~ High ~ #CHD Stroke #CVD 
~2b2tl N !9! BMI DBP SBP weiaht weiaht Obese BP dead deaths deaths death 
Charleston 454 50.4 27.3 91.9 159.9 35.5 30.4 29.1 71.6 272 73 36 162 
EVANS 555 51.3 28.6 101.2 168.3 28.5 27.6 37.8 82.7 316 89 68 200 
NHANESI 1285 47.8 27.9 87.1 141 31.8 30.8 32.3 54.4 440 100 61 216 
NHANES II 549 53.6 28.7 85.8 139 26.8 35.7 35.5 52.1 98 35 9 58 
Total 2,843 1,126 297 174 636 
BLACK MALES 
~ ~ % tL 
!!!!!!l ~ mean mean N.2!.!nru 2Y.!ll ~ High tt #CHD Stroke #CVD 
~ohon N !S.! BMI DBP ee weiaht weisht Obese BP dead deaths deaths death 
Charleston 333 49.9 25.1 90.3 151.2 51.7 32.1 12.0 66.7 226 62 26 113 
EVANS 456 51.1 25 100 159 53.7 32.2 9.9 79.6 325 73 58 172 
NHANESI 772 53.9 25.6 89.9 144.6 45.9 34.5 15.8 61.0 425 108 36 198 
NHANES II 449 54.3 25.8 87.4 137 44.1 35.9 16.7 53.2 134 29 8 46 
Total 2,010 1,110 272 128 529 
WHITE FEMALES 
:l!.. ~ % !. 
!!l.!!!1 !!l.!!!1 mean mean Normal ~ ~ High it #CHD Stroke #CVD 
Cohort N IS! BMI DBP SBP weisht welsht ~bese ,W! dead deaths deaths death 
Charleston 740 50.01 24.45 81.99 137.82 56.9 26.4 11.4 43.0 341 108 44 198 
EVANS 864 50.36 25.95 88.82 146.99 48.8 25.9 21.1 59.7 450 160 60 255 
NHANESI 6861 47.86 25.24 81.59 131.89 52.7 25.7 17.0 37.7 1687 515 174 852 
NHANES II 4274 54.53 25.94 80.64 131.54 47.9 29.4 19.3 37.3 778 197 65 349 
Total 12,739 3,256 980 343 1,654 
WHITE MALES 
.%.. .%.. :f2.. tL 
!!!!!!l !D!!!l mean mean Normal 2m ~ High tt #CHP Stroke #CVD 
~2hort N !S.! BMI DBP De wliaht weiaht Obese BP dead deaths deaths death 
Charleston 652 49.83 25.09 83.82 139.21 499 38.8 8.6 47.1 406 148 29 226 
EVANS 829 49.86 2535 89.72 143.15 46.0 37.9 12.1 58.1 566 202 74 322 
NHANESI 4803 51.56 25.72 85.12 135.88 41.4 43.6 12.2 48.0 2121 696 133 1005 
NHANES II 3815 54.42 25.94 83.98 133.86 40.7 43.7 13.7 44.4 1109 362 52 531 
Total 10,099 4,202 1,408 288 2,084 
Study Summary 
Charleston Heart Study 
The Charleston Heart study is a population-based prospective cohort study 
including 2,181 (653 white men, 741 white women, 333 black men and 454 black 
women) participants aged 35 and older representing 84% of the population-based 
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sampling plan78~79 in 1960. The study was supplemented with 102 high-SES black men 
recruited by peer nomination in 1964 when the random sampling was found to include 
only a few participants in this class. In 1960 the response rates were 8S% of white men, 
85.8% of white women, 78.3% of black men, and 84.1 % of black women and in 1964 
900/0 of the high-SES black men 80. Throughout the years, periodic searches of death 
certificates at local health departments were made. The Charleston Heart study includes 
30 years of follow-up and in 1 990 the vital status of 980/0 of whites and 99% of blacks 
was known. 
Body mass index, smoking status and diabetes status were all collected based on 
medical history 78. Blood pressure was measured in the seated position and serum 
cholesterol level was determined by the direct cholesterol method by Zlatkis. The cause 
of death was obtained from nosologists' coding of underlying cause of death on death 
certificates. Death certificates from the period of 1960-67 (which used codes from leD 
seventh edition) were recoded to leo eighth edition. 
Evans County Heart Study 
The Evans County Heart study is a community-based closed cohort including all 
black and white residents over the age of 40 and a SO% sampling of those aged IS to 3S. 
In 1960, 3,102 persons or 92% of all eligible participants were in the study including 
94% of white men, 92% of white ",,'omen, 90% of black men and 94% of black 
wonlen49;81. In 1990, after 30 years of follow-up, the vital status was known for 
approxiInately 980/0 of the participants. 
A complete and detailed medical history was obtaIned on each participant which 
includes details on past and present smoking82 . During the physical exam., three seated 
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blood pressures were taken on the left arm~ the first at arrival to the clinic, the second 30 
to 60 minutes later, and the third, 15 to 20 minutes after the first. Serum cholesterol was 
measured with the Abell-Kendall method. A complete tracing of all information 
pertaining to the circumstances and cause of death were gathered. This included copies 
of death certificates, autopsy reports, hospital and physician records, newspaper 
obituaries, and descriptions by relatives present at time of death. The information was 
reviewed by a panel consisting of three physicians and a cardiologist. A neurologist 
independently reviewed all deaths for any evidence of stroke. Criteria were established 
prior to review to classify a death. 
NHANES I Epidemiologic Follow-up Study 
NHANES I is a probability sample of the civilian, non-institutionalized United 
States population. The baseline survey consisted of 20,749 persons aged 1 to 74 years 
from 1971 to 1975. Follow-up studies were conducted from 1982 to 1984, in 1986, 1987 
and in 1992 on 14,407 persons or their proxies who were 25 to 74 years of age at 
baseline. Among persons aged 30 to 74 years, there were 10,132 white and 1,835 black 
participants. In 1993, after 20 years of follow-up, 96.20/0 of the original cohort has been 
successfully traced. Cause of death was determined from death certificates in each 
study.83-85 
NHANES II Mortality Study 
NHANES II is a probability sample of the civilian, non-institutionalized United States 
population. The baseline survey, conducted from 1976 to 1980, consisted of 20,322 
persons aged 6 months to 74 years. Mortality follow-up through matching with the 
National Death Index database for 1979 to 1992 and through the Social Security 
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Administration's Mortality Tapes Matching System for 1976 to 1988 was conducted for 
the 9,252 participants aged 30 years or older. Among participants aged 30-74 years at 
baseline there were 8,080 white and 997 blacks. Follow-up lasted for 15 years. Cause of 
death was ascertained solely by computerized matching to national databases and 
evaluation of the resulting matches83 ;85;86. 
Methods 
Subject-level Meta Analysis 
The purpose of the subject-level meta-analysis is to derive a ~'pooled" or 
combined estimate of the effect. This provides a more sensitive analysis than typical 
meta-analysis of the literature. The collection and reanalysis of individual data provides 
a reliable means of addressing questions not satisfactorily resolved in individual studies87-
92. This is accomplished by treating the data from the four studies as a single sample. 
That is, for each study a model will be fit. Then the risk factor coefficients from the 
regression in the individual studies will be combined to obtain a pooled coefficient. The 
pooled coefficients will comprise the pooled risk equation for each gender-racial group. 
The pooled estimates are NOT obtained by merging all participants into a single study. 
To obtain the pooled estimates, either a fixed effects or random effects model will 
be used. If the effects are homogenous (do not reject the null) among the studies, we use· 
a fixed effects model to obtain the pooled estimate. If there is a significant heterogeneity 
among the studies (reject the null), we use a random effects model92 . 





where Wi (= 1 / var(bD ) is the applied weight, b i the coefficient for the ith 
study and B" is the fixed effects estimate of the pooled coefficient 
(calculated below). 
Fixed Effects Model calculation for pooled coefficient: 
B " = '" W· b . / '" W· ~ I I ~ h 
As usual we use s? an estimator for a? The variance of B" is obtained from the following 
equation: 
var(B") = I w/ var(b i ) / (2: w;)2 1 / I Wi 
Random Effects Model calculation for pooled coefficient: 
B .... * = '" w·* b· I'" w·* ~ I I ~ 1, 
with variance established using the following equation: 
To estimate O'b2 , the between-study component of variance, we derive a method of 
moments estimate of ab2 by equating Ow to its expected value and solving the following 
equation: 
The max function in this equation assures us that the between-studies component of 
variance is nonnegative. 
The above methods will be used to build a pooled model for each gender-racial 
group. It is possible that some effects are fixed effects while others are random effects, 
and thus either B" or B"* will be used as the "pooled coefficient estimate" depending 
18 
whether fixed or random is appropriate for each particular parameter. 
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Abstract 
Background: The linear association between body mass index (BMI) and blood pressure 
(BP) is well established. The association between BMI and BP may vary by race, which 
has important implications for lifestyle measures to prevent and treat hypertension. This 
study examines the association between BMI and BP in black and white women and men. 
Methods: This study uses Black Pooling Project data. The average age-adjusted rises in 
BP associated with increasing BMI were calculated separately for each for each gender-
race group. Racial differences were tested with a Z-statistic. 
Results: As a group, blacks have a higher adjusted mean systolic BP than whites and are 
classified as hypertensive at all BMI categories. In contrast, mean systolic BP did not 
reach the hypertensive range in whites as a group until a BMI of at least 31 kg/m:. The 
greatest disparity in BP between blacks and whites was seen in normal weight subjects 
(15mmHg) and group differences declined to 10 mmHg in the obese. With a BMI 
increase from 25-JO kg/m2, the age-adjusted rise in BP was greater for white than black 
women (5.9±O.2 vs. 4.4±O.5 p=0.005) and for white than black men (6.0±0.3 vs. 4.3±O.7 
p=O.03). 
Conclusions: Increasing BMI has a greater impact on BP in whites than blacks. BP, 
among lean blacks as a group, is in the hypertensive range and suggests that factors other 
than BMI contribute to their elevated blood pressures. The data suggest that weight loss 
may be less effective for lowering BP in blacks than whites. 
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Introduction 
The linear association between body mass and blood pressure has long been 
recognized( 1-11). Blood pressures are on average higher in overweight and obese 
persons. Likewise, weight loss has been associated with reduction in blood 
pressure(2; 12-14) which has prompted the Seventh Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) to 
recommend weight reduction and management as strategies for high blood pressure 
control. It is estimated that a 10 kg weight loss is associated with a 5-20 mmlHg 
reduction in systolic blood pressure( 4). 
The association between body mass index and blood pressure may vary by 
race( 1; 15) and gender, which has important implications for both the pathogenesis and 
management of hypertension. The Atherosclerosis Risk in Communities (ARIC) study 
showed that body mass index and fat patterning were associated with greater risk for 
hypertension in all four gender-race subgroups including black and white men and 
women. When comparing race groups by gender, obesity and central fat pattern were 
associated with a greater risk for hypertension in white than in black women but did not 
have a differential effect in black and white men(16). Our previous work also showed 
that increased body Inass index and waist-to-hip ratio were associated with increased 
blood pressure in black and white men and women( 1). Despite the significant association 
of weight and fat pattern to blood pressure in all four gender-racial subgroups, 
hypertension rates remained significantly greater in blacks than whites after adjusting for 
body size and fat pattern. The racial difference in blood pressure persisted even after 
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adjustment for body mass and fat distribution, which suggested that other factors played a 
greater role in the pathogenesis of hypertension in blacks than whites. 
The relationship of body mass index to hypertension has important implications 
for informing lifestyle interventions to prevent and treat high blood pressure. Previous 
studies suggest that body mass index has a smaller effect on blood pressure in blacks than 
whites, particularly black than white women. Although both BMI and fat pattern are 
related to blood pressure, height and weight, required to calculate BMI, are more readily 
and commonly obtained in clinical settings. The current study uses the Black Pooling 
Project database to more fully elucidate the impact of body mass index on blood pressure 
in black and white women and men. 
Methods 
Data Source. This study uses Black Pooling Project data, which includes subject-
level data from four studies; Evans County Heart Study, Charleston Heart Study, 
NHANES I and NHANES II. The Project was established to provide an adequate 
number of black men and women to assess cardiovascular disease risks. Baseline data on 
27,691 persons (2,010 Black men, 2,843 Black women, 10,099 white men and 12,739 
white women) were collected between 1960 and 1980. In each of the studies, blood 
pressure~ total cholesterol, height and weight were measured and information on diabetes, 
and smoking status were collected in a uniform manner by trained personnel(17-21). 
Information on antihypertensive medications was obtained in NHANES I and II. 
Information was not collected for antihypertensive medication usage in Evans County 
Heart Study or Charleston Heart Study, which is reflective of the low frequency of 
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hypertension treatment in the early 60's(17). Men and women who reported use of 
antihypertensive medications were excluded from this analysis resulting in a sample size 
of 24,606 persons (1,805 Black men, 2,422 Black women, 9,190 white men and 11,189 
white women). 
Analysis. Study characteristics for each gender-race group were calculated 
according to weight categories (underweight, BMI <18.5 kg/m2, normal weight 18.5-
24.9; overweight, BMI 25.0-29.9; and obese, BMI >30). The prevalence of JNe 7 blood 
pressure categories (normal [SBP <120 mmHg and DBP <80 mmHg], pre-hypertension 
[SBP 120-139 mmHg or DBP 80-89 mmHg} , hypertension stage 1 [SBP 140-159 mmHg 
or DBP 90-99 mmHg], and hypertension stage 2 [SBP > 160 mmHg or DBP > 100 
mmHg]) and the mean BMI according to blood pressure categories were also calculated 
for each gender-race group. 
Linear regression using continuous BMI, controlling for age, cholesterol, 
diabetes, smoking status and cohort was used to calculate the average increase in systolic 
blood pressure associated with an increase in BMI. Separate regressions were fit for each 
gender-race group and the quadratic tenn, BMI2, was added to the model and included if 
significant. The adjusted mean systolic blood pressure was calculated in each BMI 
category for black and white women controlling for the mean values of age, cholesterol, 
diabetes and smoking status. The changes in blood pressure from normal weight to obese 
within each gender-race group as well as the racial differences within each weight 
category were assessed. Adjusted mean systolic blood pressure was calculated for 
thirteen categories of BMI controlling for the mean values of age, cholesterol, diabetes 
and smoking status. All analyses were gender and race specific and were performed 
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using SAS v9. O. Z-tests were used to determine whether a significant racial difference 
was present for men or women in the average increase in systolic blood pressure and in 
the mean blood pressure values associated with BM!. 
Results 
Descriptive information for our study population according to race, gender and 
weight are presented in Table 1 and 2. The prevalence of overweight and obesity was 
greater in black than white women and white than black men. Mean blood pressure 
values were greater among blacks than whites in all weight categories. The mean systolic 
and diastolic blood pressure increased with weight for both blacks and whites but more 
strongly in whites. As expected, there was an inverse relationship between BMI and the 
prevalence of current smoking. 
The prevalence of blood pressure and mean BMI by JNC 7 category are shown in 
Table 3. Normal blood pressure vvas more prevalent in whites than blacks. Among 
whites, 28% of women and 15% of men were classified with normal blood pressure 
compared to only 15% of black women and 90/0 of black men. Stage 1 and stage 2 
hypertension were more prevalent in blacks than whites. Among blacks, 61 % of women 
and 630/0 of men were classified with stage 1 or stage 2 hypertension compared to 35% of 
white women and 450/0 of white men. As blood pressure increases, using the categories 
of normal to stage 2 hypertension, the mean BMI also increases. While black women had 
a greater BM! in all blood pressure categories, the increase in mean BMI was greater in 
white women. In men, whites had a higher BMI than blacks in all blood pressure 
categories, but the increases in BM! were similar for both black and white men. 
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For each blood pressure outcome within each gender-race group, we fit one model 
adjusting only for age and cohort, and we fit another model adjusting for age, total 
cholesterol, diabetes, smoking status and cohort. For these models, the average increase 
in systolic and diastolic blood pressure associated with an increase in BMI was greater 
for whites (Table 4). This increase in systolic and diastolic blood pressure was 
significantly greater for whites than blacks in both men and women in the age and cohort 
adjusted analysis and the fully-adjusted analysis with the exception of adjusted diastolic 
blood pressure for men. 
Table 5 shows mean values for systolic BP by gender-race groups. The 
differences of blood pressure within each BMI category as well as the differences in 
blood pressure between BMI categories among each gender-race subgroups are of 
interest. When examining the data within BMI category across gender-race groups, 
alllong normal weight subjects, the racial difference was 18 mm Hg for women and 13 
mm Hg for men. Among overweight subjects, the racial difference was 16 mm Hg for 
women and 11 mm Hg for men. Among obese subjects, the racial difference was 15 mm 
Hg for women and 7 mm Hg for men. When viewing the data across BMI categories 
within the gender-race groups, the systolic BP difference between normal weight and 
obese was 13 mm Hg for black women compared to 15 mm Hg for white women and 7 
mm Hg for black men versus 13 mm Hg for white men. 
Figure 1 presents the adjusted mean systolic blood pressure according to BMI for 
each gender-race group controlling for mean values of age, cholesterol, diabetes and 
smoking status. A linear pattern between BMI and blood pressure was observed for each 
gender-race group but appears to be more pronounced in white than black men and 
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women. Blacks have a higher adjusted mean blood pressure than whites and at all levels 
of BMI blacks as a group would be classified as hypertensive. In contrast, mean blood 
pressures did not reach the hypertensive range in whites as a group until a BMI of 
approximately 31 kg/m2 in men and 33 kg/m2 in women. 
A significant racial disparity in the association between BMI and adjusted mean 
blood pressure is present for both men and women. The racial disparity in blood pressure 
is greatest among leaner persons and narrows progressively with increasing degrees of 
overweight and obesity until BMI exceeds ----38.5 kg/m2 (Figure 1). 
Figure 2 shows the racial and gender-racial blood pressure differences within 
weight categories. Racial disparities in blood pressure were greater in normal weight 
than overweight and obese subjects. The racial disparity in systolic blood pressure 
declined with increasing BMI category in both women and men, but racial differences in 
blood pressure at each category of BMI were greater for women than men. 
Discussion 
The positive relationship between body mass index and blood pressure is well 
documented (6;9; 11; 16;22;23). However, the association between BMI and blood 
pressure within gender-race groups has not been explored in the detail, and typically with 
fewer subjects than we have in our study. In our cross sectional study, there was a linear 
association observed between BMI and blood pressure (Figure 1), which was steeper in 
whites than blacks. On average, for each unit increase in BMI there is a greater increase 
in blood pressure for whites than blacks. For example, a 5 unit increase in BMI, such as 
an increase in BMI from 25 kg/m2 to 30 kg/m2, was associated with an increase in 
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systolic blood pressure of approximately 6 mmHg in white women and men and ---4.4 mm 
Hg in black women and men. 
Racial disparities in blood pressure were greater in normal weight than obese 
subjects as shown in Figure 2. In fact, regardless of BMI, systolic blood pressures of 
black women and men as a group were classified as hypertensive. In whites as a group, 
blood pressures in the hypertensive range did not occur until a BMI of 33 kg/m2 for 
women and 31 kg/m2 for men. While the racial disparity in systolic BP declined with 
increasing BMI category in both women and men, the absolute racial differences in BP at 
each category of BMI were greater for women than men. These findings suggest that 
factors other than weight contribute to racial differences in blood pressure and that these 
factors may be different and playing a greater role in women than men. However, these 
other possible factors likely do not include age, cholesterol, diabetes or smoking status, 
since we have adjusted for them in the regression models. These findings also raise the 
possibility that weight loss is less likely to normalize blood pressure in blacks than 
whites. 
These findings confirm the strong association of weight and blood pressure 
reported by others in previous studies(24). Our results also show that this association is 
stronger in whites than blacks( 1; 16) suggesting that the higher prevalence of 
hypertension in blacks might be due to factors other than weight. As noted previously, 
the rise in systolic and diastolic blood pressure with increasing BMI was greater in whites 
than blacks and the racial disparity was clinically and statistically significant. On the 
contrary, our study did not find a gender difference in the increase in systolic and 
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diastolic blood pressure associated with an increase in BMI which emphasizes the effect 
of race on this association. 
One of the limitations to this study is the lack of data on waist circumference. 
Several studies have been done to identify potential mechanisms of obesity-associated 
hypertension(22;25-27). Most of this work has focused on abdominal obesity(16). 
Abdominal obesity, estimated using waist circumference, has been linked to hypertension 
and cardiovascular disease(28-31). Data on waist circumference would have allowed a 
more comprehensive analysis of the relationship between weight and blood pressure. 
Nevertheless, the large sample size of this study provides a unique opportunity to 
examine the association using BMI, which some have found to be highly correlated to 
waist circumference (r----O.8-0.9)(16) Evidence suggests that waist circumferences at any 
BMI are similar or less in blacks than whites (32;33). These observations further suggest 
that racial differences in central body fat do not explain the higher pressures in blacks 
than whites at all BMI levels or the reduction in racial differences with increasing BMI 
categories .. although differences in the ratio of visceral to subcutaneous abdominal fat 
could playa role. 
The large and diverse population of black men and women is one of this study'S 
greatest strengths. Additionally, this study included white men and women from the 
same populations that the black men and women were derived, which allowed 
comparison of black and white men and women from the same geographic location. 
While the association between obesity and hypertension is well-documented this 
study indicates that increasing levels of body mass index have a greater impact on blood 
pressure in \\-'hites than blacks. These data suggest that the higher blood pressures in 
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blacks than whites are due to factors other than body mass, e.g., a higher set point for 
renal pressure natriuresis(34) that is independent of weight. While maintenance of a 
healthy weight is recommended for good general health, our findings raise the possibility 
that weight loss may be less effective at lowering blood pressure in blacks than whites. 
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Table 1. Gender-race specific percent distribution of BM!. 
Black Women White Women Black Men White Men 
N 2,422 11,189 1,805 9,190 
Underweight (BMI<18.5 kglm2) 4% 4% 20/0 2% 
Normal Weight (BMI 18.5-24.9 kglm2) 33% 54% 50% 43% 
Overweight (BMI 25-29.9 kg/m2) 31% 26% 34% 43% 
Obese (BMI> 30 kg/m2) 32% 16% 14% 12% 
Table 2. Selected characteristics of the four gender-race groups by BMI category. 
Black Women White Women Black Men White Men 
UNDERWEIGHT N 101 453 44 203 
Mean Age [sd] 48 [16] 46 [15] 56 [16] 57 [14] 
Mean Cholesterol [sd] 212 [37] 207 [53] 194 [36] 200 [38] 
Mean SBP [sd] 137[32] 121 [20] 143 [30] 130 [24] 
Mean DBP [sd] 83 [16] 75 [10] 88[15] 79 [12] 
Mean BMI [sd] 17.3[0.9] 17.4[1.0] 17.5 [1.0] 17.4[1.0] 
Diabetes % 6.0 2.7 0 2.5 
Current Smoker % 34 48 68 65 
NORMAL WEIGHT N 788 6,046 901 3,973 
Mean Age [sd] 47 [15] 47 [14] 52 [14] 51 [15] 
Mean Cholesterol [sd] 214 [146] 219 [40] 206 [43] 215 [43] 
Mean SBP [sd] 142 [33] 125 [21] 145 [30] 131 [20] 
Mean DBP [sd] 87 [16] 78 [10] 90 [16] 82 [11] 
Mean BMI [sd] 22.1 [1.8] 21.9[1.7] 22.2 [1.7] 22.6 [1.7] 
Diabetes % 3.1 2.0 3.0 3.1 
Current Smoker % 35 33 60 47 
OVERWEIGHT N 757 2,930 608 3,936 
Mean Age [sd] 49 [14] 52 [14] 51 [14] 52 [14] 
Mean Cholesterol [sd] 224 [50] 234 [50] 221 [48] 225 [45] 
Mean SBP [sd] 147 [33] 135 [23] 147 [28] 136[19] 
Mean DBP [sd] 89 [15] 83 [11] 92 [16] 86 [11] 
Mean BMI [sd] 27.5 [1.4] 27.1 [1.4] 27.2 27.1 [1.4] 
Diabetes % 6.8 3.7 5.0 3.6 
Current Smoker % 27 25 46 37 
OBESE N 776 1,760 252 1,078 
Mean Age [sd] 49 [13] 51 [141 52 [12] 51 [13] 
Mean Cholesterol [sd] 225 [49] 232 [52] 231 [51] 226 [44] 
Mean SBP [sd] 157 [35] 144 [25] 151 [28] 144 [22] 
Mean DBP [sd] 96 [17J 89 [121 96 [16] 91 [13] 
Mean 8MI [sd] 35.2 [5.2] 34.4 [4.4] 33.6 [3.7] 32.8 [2.9] 
Diabetes % 6.7 6.1 8.7 5.5 
Current Smoker % 23 20 37 33 
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Table 3. Prevalence of JNe 7 BP category (top) and mean [SD] BMI values (bottom). 
Black Women White Women Black Men White Men 
Normal 15% 280/0 9% 150/0 
Pre-Hypertension 240/0 37% 280/0 400/0 
Stage 1 Hypertension 230/0 210/0 290/0 280/0 
Stage 2 Hypertension 380/0 140/0 340/0 170/0 
Normal 24.7 [5.0] 22.8 [3.5] 23.4 [3.6] 23.8 [3.3] 
Pre-Hypertension 27.0 [5.6] 24.8 [4.7] 25.0 [4.2] 25.2 [3.4] 
Stage 1 Hypertension 28.2 [5.8] 26.6 [5.4] 25.6 [4.4] 26.3 [4.0] 
Stage 2 Hypertension 29.2 [7.4] 28.4 [6.4] 26.0 [4.8] 27.0 [4.5] 
* Normal: SBP <120 mmHg and DBP <80 mmHg Pre-Hypertension: SBP 120-139 mmHg or DBP 80-89 
mmHg 
Stage 1 Hypertension: SBP 140-159 mmHg or DBP 90-99 mmHg Stage 2 Hypertension: SBP 2:160 mmHg or DBP 2:100 
mmHg 
Table 4. Blood pressure increase [SE] associated with a BMI increase from 25 kg/m2 to 
30 kg/m2 
Black Women White Women p-value 
++ 
Black Men White Men p-value 
++ 
SBP* 4.4+ [0.5] 5.9+ [0.2] 0.005 4.3 [0.7] 6.0+ [OJ] 0.03 
DBP* 2.9+ [0.3] 4.0+ [0.1] 0,0005 3.4 [0.4] 4.5 [0.1] 0.008 
SBP** 4.4+ [0.5] 5.7+ [0.2] 0.02 4.2 [0.7] 5.9+ [OJ] 0.03 
DBP** 2.9~ [0.3] 3.9+ [0.1] 0.002 3.6 [0.4] 4.4+ [0.2] 0.07 
*age and cohort adjusted +quadratic term (BMI2) included in the regression 
**age, cholesterol, smoking, diabetes and cohort adjusted ++p-value testing for BP equality in blacks and whites by gender 
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Table 5. Adjusted mean systolic blood pressure values and blood pressure difference by 
BMI category. 
Black Women White Women Black Men White Men 
Underweight 138 124 139 131 
Normal Weight 145 127 143 130 
Overweight 148 132 146 135 
Obese 157 142 150 143 
~ Obese - Normal Weight 12 15 7 13 
*adjusted for mean values of age, cholesterol, diabetes and smoking status 
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Cardiovascular Disease Mortality associated with Body Mass 
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Abstract 
The relationship between BMI and CHD, stroke and CVD mortality is unclear, 
particularly among blacks. To address this gap in the literature, we used The Black 
Pooling Project database which includes 27,691 blacks and whites who were followed for 
15-30 years. The adjusted relative risks for CHD, stroke and total CVD mortality were 
estimated using subject-level meta-analysis. The results showed that obesity increased the 
adjusted relative risks for CHD, stroke and CVD mortality in whites but not in blacks. 
While obesity prevention and treatment are recommended for all, the findings suggest 
these efforts will have a greater impact on reducing CVD mortality in whites than blacks. 
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Introduction 
A growing body of literature suggests that obesity is not only related toe 1) but 
independently predicts cardiovascular disease (CVD) for both men and women(2-4). 
Evidence also indicates that minimal increases in BMI are associated with increased 
CVD risk( 5 ;6). Despite the relationship between weight and cardiovascular risk factors, 
the association between body mass index and coronary heart disease (CHD), stroke, and 
CVD mortality remain inconsistent in various epidemiological studies. 
One line of evidence indicates that total CVD mortality is associated with 
weight(3), that the risk is greater in whites than blacks(2) and that an increased(7) risk 
remains even after controlling for weight-related risk factors including hypertension, 
hyperlipidemia and diabetes(8). Results from several studies suggest a. variable 
association between BMI and CHD mortality in white men and women,(9-11) in white, 
but not black women,(12) in only white women of lower socioeconomic status(13) and in 
black but not white men(14). 
The literature also indicates a variable relationship between weight and stroke 
mortality. One study reported that weight was independently associated with stroke 
mortality,(3; 15) whereas another found that this relationship was no longer 
significant( 16) after adjusting for potential biological mediators. Other reports suggested 
that the association depends on the type of stroke( 1 7) is less pronounced in women~( 1 0) 
or that there is no association( 18-21). 
Despite a higher prevalence of obesity(22) and cardiovascular events in the black 
than white population,(23-25) studies examining the association between body mass and 
mortality in blacks and whites have typically found the mortality risk associated with 
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body mass to be greater in whites(2;26). The body mass-related increase in risk is 
suggested to begin at a 1 to 3 kg/m2 higher BMI for blacks than whites(27). 
One of the factors limiting a more definitive assessment of a differential 
relationship of weight to CVD mortality in blacks and whites is the relative paucity of 
data on black men and women. To address this limitation, the current study examines the 
relationship between body mass index and CHD, stroke, and CVD mortality in a large 
population of black and white men and women from the Black Pooling Project who were 
followed up for 15 to 30 years. 
Methods 
Data Source. This study uses data from the Black Pooling Project. The Black 
Pooling Project, which includes subject-level data from four studies; Evans County Heart 
Study, Charleston Heart Study, NHANES I and NHANES II, was established to provide 
an adequate number of black men and women to assess cardiovascular disease risks. 
Baseline data on 27,691 persons (2,010 Black men, 2,843 Black women, 10,099 white 
men and 12,739 white women) were collected between 1960 and 1980. 
In each of the studies, baseline values of blood pressure, cholesterol, height, 
weight, diabetes status and smoking status were measured or gathered in a uniform 
manner by trained personnel(13;14;28-30). Cause of death was determined from death 
certificates in each study (14;28-31) except NHANES II in vvhich mortality status was 
ascertained solely by computerized matching to national databases and evaluation of the 
resulting matches(32). In addition to death certificates, all information gathered in the 
Evans County Heart Study pertaining to death was reviewed by a panel of three 
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physicians and a cardiologist to classify the deaths. A neurologist also reviewed the 
information for evidence of stroke(29). 
Analysis. Sample size, number of CHD, stroke, and CVD deaths, number of 
contributing person-years, and the mean and prevalence of study characteristics were 
calculated for each race and gender-race group. All patient characteristics used as 
covariates in the models are baseline characteristics 
The relative risk of CHD, stroke, and CVD mortality associated with underweight 
(BMI <18.5 kg/m2), overweight (BMI 25.0-29.9 kg/m2) and obese (BMI >30 kg/m2) 
using normal weight (BMI 18.5-24.9 kg/m2) as the referent group was calculated using a 
Cox Proportional Hazard Model. Three models were evaluated. The covariates in each 
of the three models were chosen a priori. The first model (Model 1) was adjusted for age, 
the second (Model 2) was adjusted for age and smoking status, and the third (Model 3) 
was adjusted for age, hypertension, cholesterol, diabetes and smoking status. These 
models were run for each race group (black and white) and each gender-race group (black 
and white women and men) separately in each of the four cohorts and then pooled using 
meta-analysis to obtain an overall estimate. Differences between blacks and whites for 
the effect of BMI category on CHD, stroke, and CVD mortality were tested by comparing 
the regression coefficients for BMI category using a Z-statistic in men and women. 
An overall estimate of the effect was obtained using subject-level meta-analysis. 
The collection and reanalysis of subject-level data provides a .reliable means of 
addressing questions not satisfactorily resolved in individual studies(33-38)and is a more 
sensitive analysis than typical meta-analysis of the literature. This is accomplished by 
treating the data from the four studies as a single sample. That is, for each study a model 
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will be fit for each race group and each gender-race group. Then the risk factor 
coefficients from the regression in each race group or each gender-race group for the four 
individual studies will be combined to obtain a pooled coefficient. The pooled 
coefficients will comprise the pooled risk equation for each race group or each gender-
race group. Both fixed and random effects models for the study effect were used. Since 
the results from the fixed effects model were generally consistent with the results from 
the random effects model, only the results from the fixed effect model are reported. 
Results 
Descriptive information for our study population according to race and gender-
race group is presented in Table 1. Mean blood pressure values and the prevalence of 
obesity, diabetes, and current smoking status were greater among blacks than whites, 
whereas mean cholesterol values were greater for whites. 
The age-adjusted (Modell), age and smoking adjusted (Model 2), and age, 
cholesterol, diabetes, hypertension and smoking adjusted (Model 3) effects of overweight 
and obesity on relative risk [95~/o CI] of CHD, stroke, and CVD mortality were 
deternlined in blacks and whites (Table 2). In Modell, adjusted for age, overweight did 
not increase CHD, stroke or CVD mortality in either blacks or whites. However, obesity 
increased mortality for all 3 outcomes in whites but not blacks. Given that a previous 
report suggested that CVD risk began at higher BMI values for blacks than whites, we 
also examined risk associated with more severe obesity, i.e., BMI >35 kg/m2. In blacks 
with BMI >35 kg/m2, C\'D mortality was not significantly greater than in normal weight 
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blacks (1.09 [0.89-1.36]). In contrast CVD mortality tended to increase further (1.51 
[1.29 - 1.76]) among whites with BMI >35 kg/m2 . 
In Model 2, adjusted for age and smoking status, neither overweight nor obesity 
was associated with increased CHD, stroke, or CVD mortality in blacks. In contrast, 
overweight increased CHD and CVD mortality in whites and obesity increased mortality 
for all three outcomes. In Model 3, adjusted for age, cholesterol, diabetes, hypertension~ 
and smoking status, neither overweight in blacks and whites nor obesity in blacks had a 
significant effect on CHD, stroke or CVD mortality. Obesity in whites continued to 
significantly increase CHD and CVD mortality but the impact was attenuated. Of note, 
after adjusting for age, cholesterol, and diabetes but not for hypertension in whites, the 
association of obesity to stroke remained significant (1.36, [1.09-1.69]), and the 
association with CHD (1.41, [1.25-1.59]) and CVD (1.41, [1.28-1.54]) was strengthened. 
In blacks, there was no significant association of BMI to mortality in Models 1 and 2, 
which do not include hypertension as a covariate. 
The effects of BMI category on CHD, stroke and CVD morality were also 
compared between racial groups. Obesity had a greater effect on CHD (p=0.002), stroke 
(p=0.012) and CVD (p<O.OOOOI) in whites than blacks. 
T'he gender-race specific effects of overweight and obesity on the relative risk 
[950/0 CI] of CHD, stroke, and c\rD mortality were obtained using age-adjusted (Model 
1), age and smoking adjusted (Model 2), and age, cholesterol, diabetes, hypertension and 
smoking adjusted (Model 3) models (Table 3). In Modell, Model 2, and Model 3, 
overweight in black and white men and women and obesity in black men and women 
were not associated with an increase in CHD, stroke or CVD mortality. However, in 
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Model 1 and Model 2 obesity was associated with increased CHD, stroke, and CVD 
mortality in white men and women. In Model 3, obesity was associated with increased 
CHD, and CVD mortality, but not stroke mortality, in white men and women. As noted 
earlier for whites, the association between obesity and stroke mortality remained 
significant for white women (1.37, [1.02-1.83]) and white men (1.46 [1.02-2.11]) when 
hypertension was removed as a covariate from Model 3. 
Figure 1 shows the relative risk of CHD, stroke, and C\lD mortality associated 
with underweight, overweight, and obese relative to normal weight in blacks and whites 
using Model 2, adjusted for age and smoking. For whites, there is a V-shaped pattern 
with increased CHD, stroke, and CVD mortality in underweight and obese women and 
men than in normal weight and overweight women and men. In blacks, stroke and CVD 
mortality were greater in underweight women and men. In blacks, there was little 
difference in CHD mortality associated \vith underweight, overweight and obese 
compared to normal weight. 
Discussion 
Various epidemiological studies have sho'-"'n the association between BMI and 
CI-ID. stroke, and CVD mOl1ality to b~ inconsistent(2-4;9;11;12;15;20;26;39-44). The 
variable associatIons between race, BMI, and CVD mortality are likely explained by the 
comparatively slnall numbers of black participants included in most of these studies. The 
Black Pooling Project was designed to address this limitation. For this report, there are 
82,983 person-years of 0Qservation in blacks and 368,069 in whites. Our data suggests 
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that there is an association between obesity and CHD~ stroke, and CVD mortality in 
whites but not in blacks. 
Obesity was associated with increased CHD, stroke and CVD mortality in whites 
after adjusting for age (Modell) and for age and smoking (Model 2). In contrast, obesity 
was not associated with increased risk for CHD, stroke, or CVD mortality in blacks. The 
association of obesity to CHD and CVD mortality remained significant in whites after 
adj ustment for multiple comorbid risk factors (Model 3), whereas the association with 
stroke was no longer significant. Regardless of gender or race, overweight was 
associated vvith little difference in risk for CHD, stroke, or CVD mortality. 
Our group has previously reported that, 'Nhile blood pressures are greater In 
blacks than whites in all BMI categories, BMI is more strongly related to blood pressure 
in vvhites than blacks(45). These findings suggest that hypertension is an important factor 
by which obesity rnediates adverse cardiovascular effects, especially in whites. 
Pa11icularly in whites, it seems appropriate to exclude hypertension as covariate when 
assessing the contribution of obesity. "'Then excluding hypertension from the covariates 
in Model 3~ the mean hazard ratios associated "'NIth ob(;sity in whites increase for CHD 
(1.21 vs. 1.41), stroke (1.14 vs. 1.16) and CVD (1.18 VS. 1.41) mortality. In contrast, 
t~ere wer~ no significant association between obesity and rnortality in black women or 
nlen in any of the three models (Table 2). 
Obesity had a greater adverse iIupact on CHI), stroke and CVD mortality In 
whites than blacks. 'rhese observation~ ~uggest that prev~ntion and treatInent of obesity 
are likely to have greater effects to reduce deaths from heart disease, stroke and 
cardiovascular disease in \vhites than blacks. As noted above) the relationShip of obesity 
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to stroke iTIortality w'as no longer significant in whites after adjustment for cholesterol, 
diabetes, and hypertension. When hypertension 'was excluded from the list of covariates 
in Model 3, stroke mortality was 36% higher (9% - 69~o) higher in obese than normal 
weight whites. Given the strong association between BMI and blood pressure in 
whites( 46), these data suggest that prevention and treatment of obesity would likely 
decrease struke as well as CHD and CVD rnortality in whites. Moreover, the number of 
':itrokes 'vas comparati vely less than the number of C'HD and total CVD events, which 
may also contribute to the absence of a significant association between obesity and stroke 
in whItes in Model 3. 
In whites, underweight ~wa~ associated with significantly greater risk of CHD 
(1.36 [1.06-1.73J) and C:VD (1.38 [1.11-1.69J) but not stroke (1.22 [0.74-2.01]) compared 
to normal weight subjects. Among blacks, underweight compared to normal weight was 
associated with a significantly higher risk of stroke (2.19 [1.29-3.7]) and CVD (1.79 
l1.22-2.62]) bUt not CI-ID (1.05 rO.61-1.811) ~Figure 1). These findings indicate that 
under",-eight is associated with increased CVD mortality in both blacks and whites 
There is no significant racial difference in CIID, stroke, or CVD fisk associated with 
underweight whleh Inay be explained by the small number of subjects ciassified as 
underv-leight. 
The results in this analysis indicate that obesity is associated with a significantly 
greater risk of CHD, stroke and (~\TD mortality in whites but not in blacks. 'Ihis risk is 
attenuated when risk factors that are in the causal pathway, especially hypertension. are 
included as ccvariates. We did not fine. an Increase in CHI), stroke, or C:VD mortality in 
\JveniVeight men and W(lrrH;:~n which agrees with some previous studies(39) and disagrees 
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with others(9~47). Of interest, our study confirms previous reports that underweight is 
also associated with increased CVD mortality.in both whites and blacks independently of 
cigarette smoking status. 
One limitation of this study is the lack of data on body fat pattern, which typically 
includes waist circumference and/or waist:hip ratio. Previous reports indicate that a more 
centralized or abdominal fat pattern is associated ~vith increased C\TD mortality( 40;48). 
Data on waist circumference and/or waist:hip ratio ""ould have allowed a more 
comprehensive analysis of the relationship between BMI category and CHD, stroke and 
CVD mortali[y. The strength of the Black Pooling Project is the long period of follow up 
and substantial sample size of both blacks and whites, which provides a unique 
opportunity to exanline associations of BMI and CHD .. stroke~ and C~\/D rnortality. BMI 
has been highly correlated "'lith waist circumference (r---O.8-0.9)(46), and evidence 
sugges~s that \\-~aist circumferences at any B1\11 are similar or less in blacks than 
'vvhites(49;50). 
Another limitation of the study is that all patient characteristics used as covariates, 
including BMI., were obtained only at baseline. For covariates that could change over 
t1.me we may not be obtaining a true picture of the cOvariate etTect by adjusting only for 
baseline val~es HO\ivev~r, a study of ovel 17,000 rnen and women aged 20-61 years at 
baseline that tracked L:ardiovascul&T risk factors over 16 years(Sl) found a high degree of 
tracking for BMI (0.85 for men and 0.80 for v,",oInen). This suggests that baseline BMI 
can be representative of Bl\tlI later in life and suitable for predicting mortality. 
}\dditionally other studies ha"\·e suggested that BMI in early adulthood is positively 
related to CVD lTIortality later in life, :hat there 'Nas no association betvveen vveight gain 
and later mortality(52) and that. risk associated with excess weight is greater in younger 
persons( 53). 
These results confirm an association between obesity and CHD, stroke, and CVD 
mortality in whites. While the association with stroke was no longer significant in whites 
after adjusting for multiple confounders including hypertension~ weight and blood 
pressure are more strongly related in whites than blacks( 45). When hypertension is 
removed from the list of covariates in Model 3, obesity is a statistically and clinically 
significant risk factor for CHD, stroke and CVD in both white men and -women. 
Although obesity is clearly associated ·with diabetes and other health risks in African 
Americans~ our study does not show an independent relationship with CHD, stroke and 
C\TD rnortaliL) in this ra.cial group. While prevention and treatment of obesity is 
recommended for overall health, our findin.gs suggest that weight loss may be more 
effective at reducing cardiovascular disease murtality in \vhites than blacks. 
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Table 1. Sample size and study characteristics of black and white women and men. 
Black White 
Total Womefl Men Total Women Men 
N 4,853 2,843 2,010 22~838 12,739 10,099 
CVD Deaths 1165 636 529 3738 1,654 2,084 
CHD Deaths 569 297 272 2388 980 1,408 
Stroke Deaths 302 174 128 631 343 288 
Person-Years 82,893 50,881 32,012 368,069 215,400 152,669 
Age 51 1 (14) 50.1(14) 52.7 (14) 51.3 (14) 50.4 (15) 52.4 (14) 
Systolic Blood Pressure 148 (32) i49 (34) 147(29) 134 (23) 133 (25) 136 (21) 
Diastolic Blood Pressure 91 (16) 90 (16) 92 (16) 83 (12) 82 (12) 85 (12) 
Cholesterol 220 (48) 223 (49) 216 (46) I 224 (48) 227(51) 221 (45) 
Underweight C~~) 3% 4<70 30/0 3% 4% 2%> 
Overweight (%) 33°/1) 31% 49% 34~~ 45% 56~/0 
Obese (g.,~) 260/'0 34~o 14%) 1 S% 180/0 13"lo 
Diabetes (%) 60/0 70/'0 5% 40/0 4°/'0 40/0 
Non Smoker (0/0) 54?/~ 66'10 36% 460/0 59~1o 29% 
Former Smoker (%) 9?/o 60/0 130/0 210/0 11~o 3 1 ~Io 
Current Smoker (0/0) 37~1c, 28% 510/0 330/0 28°/0 400/0 
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Table 2. Impact of overweight and nbesity on adjusted* relative risk for CHD, stroke, 
and CVD mortality in blacks and \vhites. 
Modell: OVERWEIGlff OBESE 
CHD Stroke CVD CHD Stroke CVD 
0.92 0.81 0.85 1.12 0.81 0.97 
Blacks [0.75-1.12] [0.62-1.08] [0.74-0.98] [0.91-1.38] [0.61-1.09] [0.84-1.12] 
1.09 0.99 1.06 1.33 1.33 1.34 
\Vhites [0.99-1.20] [0.83-1.19] [0.98-1.14] [1.19-1.48] [1.08-1.65] [1.22-1.46] 
Model 2: 
0.95 0.84 0.89 1.01 0.84 1.02 
Black5 [0 78-1.17] [0.63- 1.13] [0.77-1.03] [0.81-1.26] [0.63-1.13] [0.88·-1.20] 
1.16 1.04 1.12 1.50 1.40 1.48 
\Vhites (1.05-1.281 [0.87-1.25] [1.04-1.201 [1.34-1.69] [1.12-·1.73] [1.35-1.62] 
Model 3: 
0.88 0.79 1).83 0.87 0.84 0.91 
Blacks [0.72-1.09] [0.5Y- 1.081 [n 72··0.97] [0.69-1.09] [0.61-1.16] [0.77 .. 1.05J 
1.04 0.97 1.01 1.21 1.14 1.18 
Whites [0.95-1.14] [0.81- 1. 1 7} [094-1.09J [1.07-1.36] [091-1 44] [1007-1,,29J 
*Model l adjusted for age 
1\1ode12 adjusted for age and slTIoking status 
Model 3 adjusted for age, cholesterol~ diabetes, hypertension, and smoking status 
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Table 3. Relative Risk of CHD, stroke and CVD mortality associated with overweight 
and Obesity in black and white women (upper) and men (lower). 
WOMEN OVERWEIGHT OBESE 
Modell: CHD Stroke CVD CHD Stroke CVD 
Blacks 1.09 [0.81-i.47] 0.87 [0 58-1.30] 090 [0.73- 1 III ' 1.21 [0.90-161] 0.98 [0.68-1.43] 1.12 [0.93-1.36] 
Whites 1.05 [0.89-1.22] 1.04· [0.81-1 33] 0.98 [0.87-1.10] 1.55 [1.32-1.81] 1.37 [1.04-1.81] 1.52 [1.34-1. 72 ] 
Model 2: 
Blacks 1.09 [0.80-1.48] 0.89 [0.58-1.37] 0.92 [0.74-1.14J 1.18 [0.88-1.60] 1.08 [0.73-1.60] 1.14 [0.94-1.39] 
White8 1.01 [0.87-1.18] 1 JJ9 lO.cl4-1.40] 1.04 [0.93-1.17] 1.67 [1.42-1.97] 1.42 [1.07-1.60] 1.61 [1.42-1.82] 
Model 3: : 
Blacks 0.9'7 [0.71-1.32] 0.81 [0.52-1.25] 0.83 [0.66-1.02] : 1.03 [0.76-1.42] 0.96 [0,64-1.45] 1.02 [0.83-1.25] , 
Whites 0.89 [0 76-1.04] 1.01 [0.78-1.31] 0.93 [0.83-1.05] : 1.32 [1.12-1.57] 1.15 [0.85-1.54] 1.27 [1.12-1.451 
, , 
MEN CHD Stroke CVD 
, 
CHD Stroke CVD , , 
Modell: 
I 
Blacks 0.8'; [0.65-1.12] 0.84 [056-1.25] 0.77 [063·0.93] : 0.94 [0.65-1.34] 0.73 [0.40-1.33] 096 [0.74-] .24] 
Whites 1.13 [1.01-1.28] 0.92 [0.71-1. 19] 1.02 [0.93-1.12] :1.32[1.12-1.~4] 1.46 (1,04-2.07] 1.32 [1.16-1.51] 
f'vlodeI2: 
Blacks o. 92 [O,69~ 1.22] 1.14 [0.76-1.731 0.91 [0.75-1.11] :0.96 [0.65-1.40] 0.74 [0.39-1.40] 0.99 [0,76-1.31] 
I 
Whiks 1.11 [0.98-1.25] 0.97 [0.'74-1.26] 1.05 (0.95-1.16] : 1.43 [1.21-1.69] 1.50 [1.05-2.14] 1.42 [1.24-1.63] 
Model 3: 
Blacks 0.88 [066-1.19] 0.79 [0.51-1.231 0.87 [0.71-1.08] :0.86 [0.57-1.28 0.65 [0.34-1.25] 0.88 [0.66-1.17 
Whites 0.99 [0.88-1.13] 0.86 [0.65-1.12] 0.95 [0.86-1.0'5] :1.18 [1.00-1.41] l.23 [0.85-1.78] 1.16 [1.01-1.34] 
*Model 1 adjusted for age 
Model 2 adjusted for age and slnoking status 
Model 3 adjusted for age~ cholesterol~ diabetes, hypertension, and smoking status 
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Figure 1. Relative Risk of CHD, stroke and CV"D mortality associated with underweight, 
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CHAPTER 4 
A paper submitted to Epidemiology 
The Association between BMI and CVD Mortality Varies with 
l\ge and _Race 
Jill E. f\bell, Brent M. Egan., Peter W. F.\Vilson, Stuart Lipsitz, Robert F. Woolson, 
l)aniel T. Lackland 
Abstract 
Background: In previous studies vve have shown that obesity is associated with 
increased cardiovascular (CVD) mortality in white women but not in black women. 
Earlier research suggests that body mass index (BMI) has a greater effect on CVD 
mortality in younger than older whites~ whereas this relationship in blacks is not as clear. 
This study examInes the effect of age on the association of BMI to CVD in black and 
white w~)m~n. 
Methods: The Black Pooling Project includes data on 2,843 black women with 50,464 
person-years of follo\-v-up and 12,739 \Nhite \-vomen with 214,606 person-years of follow-
up. A Cox proportional hazards model was UScG to exarlline the association between BMI 
and CVD lTlortality for specific age-race gruups. The younger group was < 60 years and 
the older group was> 60 years (If age. 
Rtsults: In younger whites, the relative risk tor C'/D mortality was significant in obese 
(BIvlI >30 kgltn2) ver~us normal weight (BMI 18.5-24.9 kg/m2) \-vomen (1.59[1.20·· 
2.09]). Similar1y. in older whites. the relative risk for CVD mortalit~r in obese versus 
. , 
normal weight women was significant (l.21 [1.04-1.41]). There "",'ere no such significant 
associations for black women. Overweight (BMI 25-29.9 kgim2) was net associated with 
increased risk iE black or white W{Jinen. 
Conclusion: These findings indicate that \)besity i~ ass(/ciated with a greater risk of 
CVD ITlonahty arnong v!hite but not black '''0[J1('n, ,;vith the strongest association among 
v.,'hite \VOlnen < 60 year.~. 
Introduction 
Although obe8ity represents a health risk for most populations, the risk levels 
may vary with race, and age. 1 Some studies have found that the risk of cardiovascular 
disease (CVD) mortality is associated with a high BMI,2 that the risk associated with 
obesity is greater for whites than blacks3 and that there is an independent, direct positive 
association with BMI even after controlling for variables in the causal pathway. 4 
Age impacts the association of body mass and C\lD mortality. Analysis of the 
A •.merican Cancer Society's Cancer Prevention Study data found that among men and 
wonlen aged 30-74 years~ a greater body weight vias associated with an increased risk of 
death from C VD but that the risk associated \\lith excess weight was greater in younger 
persons. 5 Data sugge8t that the prevalence vf obesity decreases after age 606 and it has 
long been questioned vvhether the ideal weight for elderly persons should be greater than 
younger persons."7 Obesity also has a profound effect on life expectancy especially 
among younger adults. 8 However in blacks~ decreased life expectancy was observed at 
hIgher B~1I levels t!1an in whites suggesting that high body Inass is not as detrimental in 
the black population. 
()verweight and obesity is a gro\\ing epidemic and major public health COnCeiTI. 
According try estlnlutes from 2003-2004~ 62~/O of US w()men were overweight or obese 
(BJ\,lI >25 kg/m2), 33~'O were obese (B~\11 >30 kg/m2) and 7% wele morbidly obese (BMI 
>40 kg/m~~).9 The prevalence of ov~rweight and ,)be:~ity varied with age and rar.e. 
Overweight and ob~sitywas greater in rniddle~age ( 40-59 years) than younger (20-40 
years) and old~:r (>60 years) Wlnnen and the prevalence was higher ir~ hlack:5 than whites 
In aU age groups fc)r wornen. \Vith the continujng rise in overweight and obesity. 
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particularly in younger adults and children., it has been suggested that this may be the first 
generation that will have a shorter lifespan than their parents. 10 
In previous studies we have found that obesity is associated \vith CVD mortality 
in whites but not in blacks. 11 This analysis examines the effect of age on the association 
ofBMI and CVD mortality in black and \\Ihite women. 
Methods 
Data Source 
This stlldy uses data from the Black Pooling Project, which includes subject-level 
data fi-oln four studies; Evans County Heart Study, Charleston Heart Study, NHANES I 
and NHANES II. The Black Pooling Project \vas established to provide an adequate 
number of black ~ubjects to assess ~ardiovas..:ular disease risks. Baseline data on 15,582 
'women (1,843 Black women and] 2,739 vvThite women) were collected between 1960 and 
1980_ FoBow~up on mortality status lasted 15-30 years and includes 265,070 person-
years. 
In each of the studies, blood preSS1lre, cholesterui, height and weight, diabetes 
status and slTIoking status were meas~red or collected in a uniforrrl_ manner by trained 
personnel. i2-i4 Cause of death was determined from death certific.ates in each study 13-17 
ex.cl~pt I'\) HANES II in vvhich mortality status \vas ascertained solely by computerized 
tnatching to national jataba~es and' evaluatIon of the resulting matches. 18 In addition to 
death certificates all information gathered in the Evans C:ounty Heart Study pertaining to 
death was revievvt!d by a panel of n-Jee physicians and a cardiologist to classify the 
deaths. }\ neurologist also r~viewed the information for any evidence of stroke: 6 
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Analysis 
Sample size, CVD deaths, person-years of follow-up, prevalence of overweight 
(BMI 25 .0-29.9kg/m2):. obesity (BMI >30 kg/m2) and other study characteristics were 
decermined for each agee-race group. The relative risk (RR) of CVD mortality associated 
with overweight and obesity were estimated with a Cox Proportional Hazard Model using 
normal weight (BMI 18.5-24.9 kg/m2) as a referent group. Three models, one controlling 
for age~ the second controlling for age and smoking and the third controlling for age~ 
hypertension, cholesterot diabetes and smoking status vvere run separately 'Nithin the 
age-race groups in each of the four cohorts. Data were pooled using subject-level meta-
analysis to obtain an overall estimate. The covariat~s in each model were selected a 
priori. Model 1 provides a crude age-adjusted me~sure of risk. Model 2 controls for age 
and smoking; smoking is a common covariate because of its association with weight. 
fvlodel 3 adjusted for age. hypeltensivn. total cholesterol, dIabetes and smoking status to 
test for associations between BrvfI and C\lD ITlortallty after controlling for known 
cardiovascular ri~k factors. 
Subject-level meta-analysis was used to calculate the overall estirnate of the 
wei.ght effect. SubJect-level rneta-analysis ~nvolves the reanalysis of subject-level data 
providing a reliable rnc&ns of addressing questions not satisfil~torily resolved in 
indi vidual studies. I c;-?~. '{'his method is a fnore st~nsiljve analysis than typical study-level 
nleta-analysis fOUild in the liter~turt;. For each study, age and race group a Inodel "vas fit. 
The rIsk factor co~fficients from the individual regression models ~Tere then conlbined to 
obtaIn (;\ pooled coeffici~nt. The pooled coefficients comprise the pooled risk equation 
for each age-{a(~t' gr0up. Both fixed and random effects models were used to obtaifl. the 
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pooled risk equation. Since the results from the fixed effect model were generally 
consistent with the results from the random effects model, only the results from the fixed 
effect model are reported. 
Results 
The prevalence of obesity in black and white women in 10-year age-groups is 
presented in Figure 1. The prevalence of obesity in black women increased from 22% in 
those younger than 30 years to 42e/o in those age 50-60 years .. After age 60, the 
prevalence of obesity began to del.;line and among those: older than 70 years 26~,tQ were 
classifIed as obese, Among w-hite women, obesity prevalence increased from 11 % in 
thos~ younger than 30 years to 21 ~/o in 50-60 year ()lds. After age 60 the prevalence of 
()besity relnaii'led constant in white \\-'omen rather than decreasing as was seen in biack 
WOlllen. 
'I able 1 presents sample size~ C\lD deaths, person-years of follow-up~ mean and 
prevalence of study characteristics for ~/ounger «60 years) and older (>60 years) black 
and white wonlen. The prevalence of o'verweight, obesity, hypertensi(ln and diahetes is 
greater in hlack than white \vnmen and incn;ases wi:h agt~. Current smoking was more 
prev[!.len( in whites and decreased with age, 
I'he relative n~k of CTvI) mortality 8.s30cia~ed with B~11 (overweight and obese), 
compare,d LO norrnal \\.ieight was calculated for each age-race group in each of the four 
studies; and pooled using m~ta-analysi:-; <Tabje 2). There ,vas little or no 6~k asso~iated 
'with-()ver\\,ielght compared to norma'! \veight in any of the four age-race groups. .L\mong 
obese 'women there "01as a significant aS50ciat~on 'Vvith CV'D mortality in younger and 
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older white women in Model·1~ Model 2J and Model :3 and for younger black women in 
Modell and Model 2 but not in Model 3. The association between obesity and CVD 
mortality was significantly greater- in younger than older whites in Modell (2.12 [1.64-
2.74] vs. 1.38 [1.20-1.59], p-value 0.013) and in Model 2 (2.49 [1.91-3.22] vs. (1.44 
[1,25-1.65], p-value 0.002). The association between obesity and CVD mortality was 
greater for younger than older white women in Model 3 (1.59 [1.20-2.11] vs.1.21 ([1.04-
1.41], p-value 0.126), but the difference was not significant. Obesity was associated with 
CVD mortality in younger but not older black women in Modell (1.39 [1.03-1.90] vs. 
0.99 [0.77-1.33J) and Model 2 (1.46 [1.07-2.01] vs. 1.18 [0.90-1.55]). Obesity was 
associated with CVD mortality in neither younger nor older black women in Model 3 
(1.23 [0.90-1.70] vs. 0.99 [0.75-1.33]). 
The association between obesity and CVD mortality was stronger in white than 
black women. This association was significantly greater in younger white than younger 
black women in Modell (2.12 rl.64-2.74] vs. 1.39 [1.03-1.90], p-value 0.04) and in 
Model 2 (2.49 [1.91-3.22] vs. 1.46 [1.07-2.01], p-value 0.012). The racial differences 
were n9t tested in Model 3 since the CVD mortality risk was not significant for younger 
black women. 
Discussion 
In previous research, ,Me found that obesity is associated with Increased CVD 
TI10rtality in white women but not black women. 11 This study extends the previous 
reports by documenting that obesity is associated with an increased risk of C\lD 
Jnortality in bot.h younger and oider white women Among white women~ the association 
between obesity and C\TD alortality is stronger in younger than older subjects. In black 
wonlen, there was an association between CVD mortality and obesity in younger but not 
older women; however this association ,vas only significant in Modell, controlling for 
age and Model 2, controlling for age and smoking status. The association between 
obesity and CVD mortality was no longer significant in Model 3, which controlled for 
hypertension, total cholesterol, and diabetes in addition to age and smoking status. The 
results 0f Model 3 suggest that the increased CVD mortality risk in younger obese black 
women is mediated in part by risk factors associated with obesIty. Overweight was not 
associated with C:\7[) mortality in any age-race group. 
These results suggest that the prevention and treatment of obesity would have the 
greatest irnpact on reducing total cardiovascular mortality in white women, especially 
those younger than 60 ytars. \\'hile there was a significant association between obesity 
and CVD mo~tality in both younger and older white women, the association was stronger 
in younger women. The observation that obesity is more strongly associated with CVD 
mortality in younger persons is consistent with previous findings. For instance, the 
Cancer Prevention Study found that elevated BMI was associated with increased CVD 
deaths but that the risk W:lS greater in younger persons. 5 In a historical cohort of men 
with a mean fnHow-up of 35 years, a strong signIficant association was found hetvveen 
Brvtl in y{)ung adulthood and CVI) mortality (HR 2.41) and a weaker, non-signifi~ant 
asso~iation for Bl\1I jn mid-adulthood (HR 1.33 ).25 In a prospective study of 6~ 193 
obese patients., th~ risk of death increased vlith body vtleight, but obesity-related excess 
nlortality dcc.iined "with age at all levels of mortality. 26 A report from the Longitudinal 
Study of A.ging suggested that ob(~sity ffiIf.,ht be protective in older community dwelling 
A.rnericans conlpared to being thin or of nornlal 'Neight.27 I'he lack of association 
between CVD mortality and overweight in blacks and whites and obesity in blacks is also 
consistent with previous findings.2~11 In the present study, this lack of association 
between overweight and CVD mortality persists among both younger and older subjects. 
The suggestion that an increased body mass affects people differently is not a 
novel idea. There has long been the discussion that the ideal weight for elderly persons 
should be greater than younger persons,7 and it has been shown that after age 60 the 
prevalence of obesity decreases.6 One explanation for this phenomenon includes 
selective survival, where obese young and middle-aged persons die prematurely. A 
second possible explanation is a cohort effect, where older persons come from cohorts 
that typically were not obese or that body fat is redistributed with increasing age. 6 It is 
also possible that older subjects, even at a normal BMI, have less lean mass and .more 
adiposity which raises their CVD risk closer to levels of the obese. In this study, the 
prevalence of obesity peaked between 50-60 years in black women and then began to 
decline. H{)w-ever in white women, the'prevalence of obesity peaked at 50-60 years and 
then remained constant across the older age groups. 
One of the limitations in this study is that all study characteristics were collected 
only at baseline. We do not have additional measures of the covariates to assess whether 
weight or other risk factor changes during the 15 to 30 years of follow-up might have 
affected the results. However it has been suggested in a study of men, that BMI in early 
adulthood is positively related to CVD mortality later in life and that an association 
between weight gain and later mortality was not found25 . Although that study focused on 
men and not women, the results suggest that weight early in life might be a better 
predictor of CVD mortality than multiple measures or measures later in life. Another 
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limitation to this study is the lack of data on waist circumference, a commonly used 
measure of visceral fat. Previous reports indicate that a more centralized or abdominal fat 
pattern is associated with increased CVD mortality.28 Data on waist circumference may 
have allowed a more comprehensive analysis of the association between BMI and CVD 
mortality. However BMI has been found to be highly correlated with waist 
circumference (r--0.8-0.9),29 and evidence suggests that waist circumferences at any BMI 
are similar or less in blacks than whites.30;31 
These results suggest that there is an association between obesity and CVD 
mortality in younger and older white women. Among white women obesity is associated 
with a greater CVD mortality risk in women younger than 60 years of age. This is 
particularly important as the prevalence of obesity in children and younger adults being 
classified as overweight and obese continues to increase. As the prevalence of obesity 
increases in younger women it is reasonable to assume that the number of women at 
increased risk of CVD mortality will also increase. Hence, obesity treatment and 
prevention would most likely have the greatest Impact on reducing CVD mortality in 
white \-vomen, particularly those under age 60. While obesity was not independently 
associated with CVD mortality in blacks, a significant association in younger black 
women was observed until adjustment was made for obesity-associated risk factors 
including hypertension and diabetes. Since medical management of risk factors can be 
suboptimal, weight loss, which improves multiple cardiovascular risk factors, is likely to 
reduce cardiovascular mortality in younger black women. Given non-cardiovascular 
health risks of obesity, which include degenerative joint disease and several cancers, the 
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outcomes, stroke and CVD mortality and 
subgroups. purpose of this ass;es~)mlen[ was 
relationship between BMI and cardiovascular 'LI' .... 'k"'-''LJL~.L ... -'oJ 
WOI11.en. 
BMI and blood ...... ...-.0."'''' .... · .... 13 in black 
women. We found that while the ..... "'.L""'~ .... association BMI 
BMI have a rY<O"c • ..-.1<"" .. "" impact on blood 
Blood pressure, even among lean blacks as a In 
",. ........ L'.·C' that ......... V~\J.L other than BMI contribute to their 
data 
blacks than 
that weight n1ay be less effective 
",,'U"',,",,". at the '=''''0'''''''''' BMI and CHD, stroke and CVD 
study showed that increased the adjusted 
mortality in men and women but not in black men 






BMI, in particular 
was more 
..... "" .. J"' ... '''' ...... '..., .... with cardiovascular "' ..... ''"'''"'''''4''''''''.,'''' 
nlen men women. 
men and \vomen, be 
high .. ,.T·f-O',';;t",""'",J. ... ,""' or 
other ~i;~"c,J.'~".lrL"L,J. ... "',J."' ... of cause should 
a healthy weight should be recomnlended 
men a on blood 
a and CVI) Inortality in 
should assess the mUltiple that blood 
had a high hypertension in 
were as a as it 
women 
body mass. loss 
1 
Similarly, obesity was associated with CHD, stroke and CVD mortality 
differently for blacks and whites. Like blood pressure~ CHD, stroke CVD mortality was 
more highly associated with obesity in white men and women than in black men and 
women suggesting mechanisms independent of body mass. 
Future research should also focus on the translation of these results to clinical 
practice. While our research suggests that weight loss affects blood pressure and 
cardiovascular mortality differently in blacks and whites, weight loss intervention studies 
that inc1ude both blacks and \\-'hites should be conducted to truly understand these results. 
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